Cargando…
Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM-1 human myelodysplastic syndrome cell line
Although certain combination therapies comprising arsenic trioxide (As(2)O(3)) with other agents exist for the treatment of several types of human cancer, few As(2)O(3) combination therapies are clinically effective for myelodysplastic syndromes (MDS). Triptolide (TL) may be an effective therapeutic...
Autores principales: | Hua, Hai-Ying, Gao, Hua-Qiang, Sun, Ai-Ning, Cen, Jian-Nong, Wu, Li-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101914/ https://www.ncbi.nlm.nih.gov/pubmed/27665715 http://dx.doi.org/10.3892/mmr.2016.5779 |
Ejemplares similares
-
Arsenic trioxide induces apoptosis in the THP1 cell line by downregulating EVI-1
por: ZHOU, LING-YUN, et al.
Publicado: (2014) -
Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis
por: Zhang, Jing, et al.
Publicado: (2015) -
Synergistic Effects of Arsenic Trioxide and Radiation: Triggering the Intrinsic Pathway of Apoptosis
por: Moloudi, Kave, et al.
Publicado: (2017) -
In Vitro Evaluation of Two Novel Antimalarial Derivatives of SKM13: SKM13-MeO and SKM13-F
por: Trinh, Thuy-Tien Thi, et al.
Publicado: (2022) -
Anti-malarial activity of HCl salt of SKM13 (SKM13-2HCl)
por: Trinh, Thuy-Tien Thi, et al.
Publicado: (2022)